Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies ...

Eukaryogenesis occurred suddenly, driven by the growing length of genes and the limitations on producing longer proteins. An ...

AnelloBricks is a promising in vitro approach to producing a new class of functional viral vectors, offering dramatic ...

DNA (deoxyribonucleic acid) is the nucleic acid polymer that forms the genetic code for a cell or virus. Most DNA molecules consist of two polymers (double-stranded) of four nucleotides that each ...

The Derbyshire, England-based pharmaceutical company said the testing on mice evaluated the use of its Nuvec proof-of-concept programme, N4 101, which is an orally delivered anti-inflammatory ...

Maravai LifeSciences MRVI is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors ...

Mitochondrial diseases affect approximately 1 in 5,000 people worldwide, causing debilitating symptoms ranging from muscle weakness to stroke-like episodes. Some of these conditions result from ...

As the demand for viral vectors rises in new gene therapy approaches, scientists seek ways to optimize their production.

Many mitochondrial diseases have been difficult to study and treat due to the inherent challenges in accessing mitochondrial DNA (mtDNA). Now, researchers have optimized mitochondrial-targeted ...

Mitochondrial diseases affect approximately 1 in 5,000 people worldwide, causing debilitating symptoms ranging from muscle weakness to stroke-like episodes.